556 related articles for article (PubMed ID: 17253900)
1. Antiviral resistance and the control of pandemic influenza.
Lipsitch M; Cohen T; Murray M; Levin BR
PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
[TBL] [Abstract][Full Text] [Related]
2. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.
Leung K; Lipsitch M; Yuen KY; Wu JT
Lancet Infect Dis; 2017 Mar; 17(3):339-347. PubMed ID: 27914853
[TBL] [Abstract][Full Text] [Related]
4. Modeling the effects of drug resistant influenza virus in a pandemic.
Brockmann SO; Schwehm M; Duerr HP; Witschi M; Koch D; Vidondo B; Eichner M
Virol J; 2008 Oct; 5():133. PubMed ID: 18973656
[TBL] [Abstract][Full Text] [Related]
5. [High prevalence of antiviral resistant influenza, and reduced clinical effectiveness of the antivirals against resistant influenza strains].
Saito R
Jpn J Antibiot; 2010 Feb; 63(1):81-91. PubMed ID: 20836406
[No Abstract] [Full Text] [Related]
6. Post-exposure prophylaxis during pandemic outbreaks.
Moghadas SM; Bowman CS; Röst G; Fisman DN; Wu J
BMC Med; 2009 Dec; 7():73. PubMed ID: 19954514
[TBL] [Abstract][Full Text] [Related]
7. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
8. Antiviral prophylaxis during pandemic influenza may increase drug resistance.
Eichner M; Schwehm M; Duerr HP; Witschi M; Koch D; Brockmann SO; Vidondo B
BMC Infect Dis; 2009 Jan; 9():4. PubMed ID: 19154598
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
10. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
Handel A; Longini IM; Antia R
J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
[TBL] [Abstract][Full Text] [Related]
11. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
[No Abstract] [Full Text] [Related]
12. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
13. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
14. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
Ward P; Small I; Smith J; Suter P; Dutkowski R
J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
[TBL] [Abstract][Full Text] [Related]
15. Antivirals and the control of influenza outbreaks.
Hota S; McGeer A
Clin Infect Dis; 2007 Nov; 45(10):1362-8. PubMed ID: 17968836
[TBL] [Abstract][Full Text] [Related]
16. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
17. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
20. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
McCaw JM; Wood JG; McCaw CT; McVernon J
PLoS One; 2008 Jun; 3(6):e2362. PubMed ID: 18523549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
